Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Brems

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|May 1, 2013
Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiencyMagdalena Chmara, Annekatrin Wernstedt, Bartosz Wasag, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint InhibitorsLisa Kinget, Oliver Bechter, Kevin Punie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 2, 2009
Spred1 is required for synaptic plasticity and hippocampus-dependent learningEllen Denayer, Tariq Ahmed, Hilde Brems, et al.
Journal of Medical Genetics|June 2, 2024
Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the <i>NF1</i> geneSteven Smeijers, Hilde Brems, Alexander Verhaeghe, et al.
The Journal of Biological Chemistry|November 7, 2024
Legius syndrome mutations in the Ras-regulator SPRED1 abolish its membrane localization and potentially cause neurodegenerationYasuko Hirata, Hilde Brems, Seppe Van der Auweraer, et al.
Cancers|October 29, 2025
Reply to Taal et al. Comment on "Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. <i>Cancers</i> 2025, <i>17</i>, 1306"Maria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.
Cancers|April 26, 2025
Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath TumourMaria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.
BMC Medical Genetics|September 24, 2009
Pathogenesis of vestibular schwannoma in ring chromosome 22Ellen Denayer, Hilde Brems, Paul de Cock, et al.
Human Mutation|August 31, 2006
Comprehensive NF1 screening on cultured Schwann cells from neurofibromasOphélia Maertens, Hilde Brems, Jo Vandesompele, et al.
Genes, Chromosomes & Cancer|July 11, 2006
Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patientsThomas De Raedt, Ophélia Maertens, Magdalena Chmara, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|May 1, 2013
Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiencyMagdalena Chmara, Annekatrin Wernstedt, Bartosz Wasag, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint InhibitorsLisa Kinget, Oliver Bechter, Kevin Punie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 2, 2009
Spred1 is required for synaptic plasticity and hippocampus-dependent learningEllen Denayer, Tariq Ahmed, Hilde Brems, et al.
Journal of Medical Genetics|June 2, 2024
Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the <i>NF1</i> geneSteven Smeijers, Hilde Brems, Alexander Verhaeghe, et al.
The Journal of Biological Chemistry|November 7, 2024
Legius syndrome mutations in the Ras-regulator SPRED1 abolish its membrane localization and potentially cause neurodegenerationYasuko Hirata, Hilde Brems, Seppe Van der Auweraer, et al.
Cancers|October 29, 2025
Reply to Taal et al. Comment on "Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. <i>Cancers</i> 2025, <i>17</i>, 1306"Maria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.
Cancers|April 26, 2025
Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath TumourMaria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.
BMC Medical Genetics|September 24, 2009
Pathogenesis of vestibular schwannoma in ring chromosome 22Ellen Denayer, Hilde Brems, Paul de Cock, et al.
Human Mutation|August 31, 2006
Comprehensive NF1 screening on cultured Schwann cells from neurofibromasOphélia Maertens, Hilde Brems, Jo Vandesompele, et al.
Genes, Chromosomes & Cancer|July 11, 2006
Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patientsThomas De Raedt, Ophélia Maertens, Magdalena Chmara, et al.
Pageof 8